Search

Your search keyword '"Insmed Inc. -- Forecasts and trends"' showing total 21 results
Start Over Descriptor "Insmed Inc. -- Forecasts and trends"
21 results on '"Insmed Inc. -- Forecasts and trends"'

1. Pulmonary Arterial Hypertension Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Novartis, Insmed Inc, Chugai Pharma, Merck Sharp & Dohme, Janssen

Subjects
United States. Food and Drug Administration -- Statistics -- Reports, Merck & Company Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, BCG vaccines -- Statistics, BCG -- Statistics, Treprostinil -- Statistics, Epidemiology -- Forecasts and trends -- Reports -- Statistics, Pulmonary hypertension -- Forecasts and trends -- Reports -- Statistics, Pharmaceutical industry -- Statistics -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international, World Health Organization -- Statistics -- Growth -- Reports
Abstract

M2 PRESSWIRE-April 25, 2024-: Pulmonary Arterial Hypertension Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Novartis, Insmed Inc, Chugai Pharma, Merck Sharp & Dohme, Janssen [...]

Published
2024

2. PH-ILD Market Analysis 2032 Unveils Breakthrough Therapies and Regulatory Milestones from DelveInsight, Featuring Leading Innovators Insmed Incorporated, Bellerophon Therapeutics, United Therapeutics

Subjects
Insmed Inc. -- Forecasts and trends, Long-distance telephone service -- Forecasts and trends -- Reports, Business -- Research, Lung diseases -- Forecasts and trends -- Reports, BCG vaccines -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pulmonary hypertension -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Long-distance telephone service, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-February 16, 2024-: PH-ILD Market Analysis 2032 Unveils Breakthrough Therapies and Regulatory Milestones from DelveInsight, Featuring Leading Innovators Insmed Incorporated, Bellerophon Therapeutics, United Therapeutics, (C)1994-2024 M2 COMMUNICATIONS RDATE:15022024 DelveInsight's [...]

Published
2024

3. Non-Cystic Fibrosis Bronchiectasis (NCFB) Market Poised for Phenomenal Expansion During the Forecast Period (2023-32) - DelveInsight | Insmed, AstraZeneca, Zambon, CSL Behring, Renovion, Armata Pharma

Subjects
AstraZeneca PLC -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, Business -- Research, Cystic fibrosis -- Forecasts and trends, Brand equity -- Forecasts and trends, Bronchiectasis -- Forecasts and trends, Epidemiology -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-January 18, 2024-: Non-Cystic Fibrosis Bronchiectasis (NCFB) Market Poised for Phenomenal Expansion During the Forecast Period (2023-32) - DelveInsight | Insmed, AstraZeneca, Zambon, CSL Behring, Renovion, Armata Pharma (C)1994-2024 [...]

Published
2024

4. Pseudomonas Aeruginosa Infection Market to Witness Growth by 2032, Estimates DelveInsight | Companies - BiomX, Inc., Armata Pharmaceuticals, VectorB2B, Insmed Incorporated, Mylan Inc., Joseph L. Kuti

Subjects
Mylan Inc. -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, Business -- Research, Infection -- Forecasts and trends -- Health aspects, Brand equity -- Health aspects -- Forecasts and trends, Epidemiology -- Forecasts and trends -- Health aspects, Pharmaceutical industry -- Forecasts and trends, Pseudomonas aeruginosa -- Growth -- Health aspects -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-November 7, 2023-: Pseudomonas Aeruginosa Infection Market to Witness Growth by 2032, Estimates DelveInsight | Companies - BiomX, Inc., Armata Pharmaceuticals, VectorB2B, Insmed Incorporated, Mylan Inc., Joseph L. Kuti [...]

Published
2023

5. Pulmonary Hypertension Associated with Interstitial Lung Disease Market Size in the 7MM was approx. USD 1200 Million in 2022, estimates DelveInsight

Subjects
Insmed Inc. -- Forecasts and trends, Business -- Research, Lung diseases -- Forecasts and trends -- Reports, Respiratory agents -- Reports -- Forecasts and trends, Treprostinil -- Forecasts and trends -- Reports, Pulmonary hypertension -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-September 22, 2023-: Pulmonary Hypertension Associated with Interstitial Lung Disease Market Size in the 7MM was approx. USD 1200 Million in 2022, estimates DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:21092023 The [...]

Published
2023

6. Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer Bio

Subjects
United Therapeutics Corp. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Acceleron Pharma Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, Business -- Research, Biotechnology industry -- Forecasts and trends, Treprostinil -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Hypertension -- Forecasts and trends -- Reports, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Hypertension Market Insights report includes a comprehensive understanding of current treatment practices, hypertension emerging drugs, market share [...]

Published
2023

7. Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer Bio

Subjects
United Therapeutics Corp. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Acceleron Pharma Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, Business -- Research, Biotechnology industry -- Forecasts and trends, Treprostinil -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Hypertension -- Forecasts and trends -- Reports, Market trend/market analysis, Business, News, opinion and commentary
Abstract

According to DelveInsight, the hypertension market in the 7MM is expected to significantly change during the study period 2019--2032. While the hypertension market has generally shown a positive trend, certain [...]

Published
2023

8. Pulmonary Hypertension Associated with Interstitial Lung Disease Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight

Subjects
Insmed Inc. -- Forecasts and trends, Business -- Research, Lung diseases -- Forecasts and trends -- Reports, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pulmonary hypertension -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 26, 2023-: Pulmonary Hypertension Associated with Interstitial Lung Disease Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:26062023 DelveInsight's 'Pulmonary [...]

Published
2023

9. Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight

Subjects
Insmed Inc. -- Forecasts and trends, Business -- Research, Lung diseases -- Forecasts and trends -- Reports, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Treprostinil -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pulmonary hypertension -- Forecasts and trends -- Reports, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 10, 2023-: Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight (C)1994-2023 [...]

Published
2023

10. Executives and Analysts Converge at the 30th Annual Emerald Groundhog Day Investment Forum on February 2nd

Subjects
Carpenter Technology Corp. -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, Executives -- Forecasts and trends, Steel industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LANCASTER: Emerald Advisers, LLC celebrated 30 years of managing client funds in 2022, and its portfolio managers and research analysts help kick off 2023 by presenting their insights and outlook [...]

Published
2023

11. Non-Cystic Fibrosis Bronchiectasis Market Report 2022: Featuring Key Players Aradigm Corporation, Zambon, Novartis Pharmaceuticals & Insmed Incorporated - ResearchAndMarkets.com

Subjects
Novartis Pharma AG -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, Medical research -- Forecasts and trends, Medicine, Experimental -- Forecasts and trends, Cystic fibrosis -- Forecasts and trends, Bronchiectasis -- Forecasts and trends, Epidemiology -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Non-Cystic Fibrosis Bronchiectasis (NCFB) - Market Insight, Epidemiology and Market Forecast -2032' report has been added to ResearchAndMarkets.com's offering. This 'Non-Cystic Fibrosis Bronchiectasis (NCFB)- Market Insights, Epidemiology, [...]

Published
2022

12. Non-Cystic Fibrosis Bronchiectasis Market Report 2022: Featuring Key Players Aradigm Corporation, Zambon, Novartis Pharmaceuticals & Insmed Incorporated

Subjects
Novartis Pharma AG -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, Cystic fibrosis -- Forecasts and trends, Bronchiectasis -- Forecasts and trends, Epidemiology -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-July 5, 2022-: Non-Cystic Fibrosis Bronchiectasis Market Report 2022: Featuring Key Players Aradigm Corporation, Zambon, Novartis Pharmaceuticals & Insmed Incorporated (C)1994-2022 M2 COMMUNICATIONS RDATE:05072022 The 'Non-Cystic Fibrosis Bronchiectasis (NCFB) [...]

Published
2022

13. The Bronchiectasis market outlook is expected to change positively in the upcoming years because of increased global healthcare spending, improved awareness, and the proliferation of major players

Subjects
Novartis Pharma AG -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, Business -- Research, Medical economics -- Statistics -- Forecasts and trends, Bronchiectasis -- Forecasts and trends -- Statistics, Epidemiology -- Forecasts and trends -- Statistics, Pharmaceutical industry -- Statistics -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-August 10, 2021-: The Bronchiectasis market outlook is expected to change positively in the upcoming years because of increased global healthcare spending, improved awareness, and the proliferation of major [...]

Published
2021

14. Consolidated Research: 2019 Summary Expectations for Exxon Mobil, Chesapeake Energy, Booking, Insmed, Altair Engineering, and MobileIron -- Fundamental Analysis, Key Performance Indications

Subjects
Chesapeake Energy Corp. -- Forecasts and trends, Booking Holdings Inc. -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, Altair Engineering Inc. -- Forecasts and trends, Exxon Mobil Corp. -- Forecasts and trends, Information services -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Engineering services -- Forecasts and trends, Petroleum industry -- Forecasts and trends, Energy industries, Stockholders, Accounting departments, Information services industry, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

NEW YORK, April 03, Apr 03, 2019 (GLOBE NEWSWIRE via COMTEX) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for [...]

Published
2019

15. Market Trends Toward New Normal in lululemon athletica inc, Insmed, Advanced Disposal Services, AGCO, Douglas Dynamics, and Ballard Power -- Emerging Consolidated Expectations, Analyst Ratings

Subjects
Insmed Inc. -- Forecasts and trends, Douglas Dynamics Inc. -- Forecasts and trends, Ballard Power Systems Inc. -- Forecasts and trends, lululemon athletica inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Construction equipment industry -- Forecasts and trends, Fuel cell industry -- Forecasts and trends, Clothing industry -- Forecasts and trends, Agricultural equipment industry -- Forecasts and trends, Stockholders, Accounting departments, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Market Source Research has issued the following news release:In new independent research reports released early this morning, Market Source Research released its latest key findings for all current [...]

Published
2019

16. Market Trends Toward New Normal in lululemon athletica inc, Insmed, Advanced Disposal Services, AGCO, Douglas Dynamics, and Ballard Power -- Emerging Consolidated Expectations, Analyst Ratings

Subjects
Insmed Inc. -- Forecasts and trends, Douglas Dynamics Inc. -- Forecasts and trends, Ballard Power Systems Inc. -- Forecasts and trends, lululemon athletica inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Construction equipment industry -- Forecasts and trends, Fuel cell industry -- Forecasts and trends, Clothing industry -- Forecasts and trends, Agricultural equipment industry -- Forecasts and trends, Stockholders, Accounting departments, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

NEW YORK, Feb 07, 2019 (GLOBE NEWSWIRE via COMTEX) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current [...]

Published
2019

17. Recent Analysis Shows Northwest Natural Gas, Brooks Automation, Insmed, Host Hotels & Resorts, Prospect Capital, and Inphi Market Influences -- Renewed Outlook, Key Drivers of Growth

Subjects
Host Hotels & Resorts Inc. -- Forecasts and trends, Inphi Corp. -- Forecasts and trends, Northwest Natural Gas Co. -- Forecasts and trends, Brooks Automation Inc. -- Forecasts and trends, Prospect Capital Corp. -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, Investment companies -- Forecasts and trends, Hotels and motels -- Forecasts and trends -- United States, Industrial equipment industry -- Forecasts and trends, Gas utilities -- Forecasts and trends, Real estate investment trusts -- Forecasts and trends, Natural gas, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

NEW YORK, May 30, May 30, 2018 (GLOBE NEWSWIRE via COMTEX) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all [...]

Published
2018

18. Market Trends Toward New Normal in Insmed, Hudson Technologies, East West, Ringcentral, Armstrong Flooring, and Host Hotels & Resorts -- Emerging Consolidated Expectations, Analyst Ratings

Subjects
Host Hotels & Resorts Inc. -- Forecasts and trends, Hudson Technologies Inc. -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, East West Bancorp Inc. -- Forecasts and trends, Floor covering industry -- Forecasts and trends, Hotels and motels -- Forecasts and trends -- Evaluation -- United States, Real estate investment trusts -- Forecasts and trends -- Evaluation, Banking industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Banking industry, Banking, finance and accounting industries, Business
Abstract

NEW YORK, Feb 12, 2018 (GLOBE NEWSWIRE via COMTEX) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, [...]

Published
2018

19. Organizational Transitions, Patient Enrollment, Initiation of Clinical Programs, Financial Outlook, and Corporate Updates - Analyst Notes on Insmed, Akebia, Retrophin, Agios and Spectranetics

Subjects
Spectranetics Corp. -- Forecasts and trends, Insmed Inc. -- Forecasts and trends, Laser industry -- Forecasts and trends, Economic forecasting, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, April 23, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Insmed Incorporated (NASDAQ: [...]

Published
2014

20. Analysis, Outlooks Posted for RAS, SCLW, and INSM at SmallCapNetwork.com

Subjects
Insmed Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, general
Abstract

Insmed Incorporated (NASDAQ:INSM), penny stock Socialwise, Inc. (OTC:SCLW), and RAIT Financial Trust (NYSE:RAS) are examined for trade-worthiness at the smallcapnetwork.com community pages. (Vocus) March 3, 2010 -- The Small Cap [...]

Published
2010

21. Highlights of rising and falling U.S. stocks

Subjects
Insmed Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international, News, opinion and commentary, Fluvirin (Vaccine)
Abstract

(From CBS Marketwatch (Stories)) Byline: ZEINA KARAM Stocks to watch 3M Co. reported third-quarter earnings of $853 million, or $1.10 a share, up from a year-ago profit of $775 million, [...]

Published
2005

Catalog

Books, media, physical & digital resources
See catalog results